Product Description: Revdofilimab (ABBV-368) is a human IgG1 agonist monoclonal antibody against OX40. Among them, OX40 is a member of the TNF receptor superfamily expressed on activated and memory T cell subsets and T regulatory cells[1].
Applications: COVID-19-immunoregulation
Formula: N/A
References: [1]A. Spira, et al. Safety, tolerability, and pharmacokinetics of the OX40 agonist ABBV-368 in patients with advanced solid tumors. ABSTRACTS IMMUNOTHERAPY OF CANCER/ VOLUME 29, SUPPLEMENT 8, VIII409, OCTOBER 2018
CAS Number: 2230138-89-1
Molecular Weight: N/A
Compound Purity: 99.35
Research Area: Cancer; Inflammation/Immunology
Solubility: 10 mM in DMSO
Target: Orexin Receptor (OX Receptor)